The case: Myriad at the Supreme Court Managing

Intellectual Property
September 2013

Messrs. Fischer, Carlin and Rothman discuss the recent Myriad decision, in which the Supreme Court held that naturally occurring DNA is not patentable subject matter. The tea leaf reading is over and we now have the decision providing guidance on bounds of patentable subject matter in the life sciences. The issue remains, what will it mean for the scientific community and for innovation going forward.

View Attachment (PDF)